Document is current
Any future updates will be listed below
-
Authors
Hatcher, Simon https://orcid.org/0000-0003-3117-2350
Heisel, Marnin
Ayonrinde, Oyedeji
Campbell, Julie K.
Colman, Ian
Corsi, Daniel J.
Edgar, Nicole E.
Gillett, Lindsay
Kennedy, Sidney H.
Hunt, Sophia Lakatoo
Links, Paul
MacLean, Sarah
Mehta, Viraj
Mushquash, Christopher
Raimundo, Alicia
Rizvi, Sakina J.
Saskin, Refik
Schaffer, Ayal
Sidahmed, Alaaddin
Sinyor, Mark
Soares, Claudio
Taljaard, Monica
Testa, Valerie
Thavorn, Kednapa
Thiruganasambandamoorthy, Venkatesh
Vaillancourt, Christian
-
Funding
Funding for this research was provided by:
Ontario SPOR Support Unit (IA2014-405046)
- License Information
-
More Information
Article History
Received: 3 March 2020
Accepted: 16 May 2020
First Online: 13 November 2020
Ethics approval and consent to participate {24}
: This protocol has received research ethics board (REB) approval from the OHSN-REB via Clinical Trials Ontario (CTO reference CTO-790). The OHSN-REB granted a waiver of individual consent for this protocol under Chapter 2, Article 2.4 of the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans. All study sites have received provincial approval, and individual site submissions are currently ongoing.
: These are available from the corresponding author upon request.
: The study investigators have the following competing interests to declare: SJR is a coinvestigator with the Canadian Biomarker Integration Network in Depression (CAN-BIND), funded by the Ontario Brain Institute (OBI). She also received research grant funding from Pfizer Canada. The other authors declare that they have no competing interests.
